Annual FCF
N/A
December 31, 2024
Summary
- SLN annual free cash flow is not available.
Performance
SLN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
N/A
December 1, 2024
Summary
- SLN quarterly free cash flow is not available.
Performance
SLN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
December 1, 2024
Summary
- SLN TTM free cash flow is not available.
Performance
SLN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SLN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
SLN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Silence Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.28 M(+340.6%) | -$59.53 M(+59.7%) |
| Jun 2024 | - | -$6.19 M(-34.6%) | -$37.29 M(-25.6%) |
| Mar 2024 | - | -$9.46 M(-43.0%) | -$50.12 M(-0.1%) |
| Dec 2023 | -$50.19 M(-9.6%) | -$16.60 M(+229.6%) | -$50.19 M(-5.6%) |
| Sep 2023 | - | -$5.04 M(-73.5%) | -$53.19 M(-5.9%) |
| Jun 2023 | - | -$19.03 M(+99.8%) | -$56.52 M(+22.4%) |
| Mar 2023 | - | -$9.52 M(-51.4%) | -$46.18 M(-16.9%) |
| Dec 2022 | -$55.54 M(-852.1%) | -$19.60 M(+134.3%) | -$55.54 M(+40.3%) |
| Sep 2022 | - | -$8.37 M(-3.7%) | -$39.60 M(+1.9%) |
| Jun 2022 | - | -$8.69 M(-54.0%) | -$38.85 M(-855.6%) |
| Mar 2022 | - | -$18.88 M(+415.8%) | $5.14 M(-30.4%) |
| Dec 2021 | $7.39 M(-148.0%) | -$3.66 M(-51.9%) | $7.39 M(-33.1%) |
| Sep 2021 | - | -$7.62 M(-121.6%) | $11.05 M(-40.8%) |
| Jun 2021 | - | $35.30 M(-312.2%) | $18.66 M(-212.2%) |
| Mar 2021 | - | -$16.64 M | -$16.64 M |
| Dec 2020 | -$15.39 M(-783.0%) | - | - |
| Dec 2019 | $2.25 M(-110.5%) | - | - |
| Dec 2018 | -$21.51 M(+62.8%) | - | - |
| Dec 2017 | -$13.21 M(+0.9%) | - | - |
| Dec 2016 | -$13.08 M(-3.0%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$13.49 M(-11.5%) | - | - |
| Dec 2014 | -$15.24 M(+34.1%) | - | - |
| Dec 2013 | -$11.37 M(+38.5%) | - | - |
| Dec 2012 | -$8.21 M(-1.6%) | - | - |
| Dec 2011 | -$8.34 M(-50.2%) | - | - |
| Dec 2010 | -$16.74 M(+112.4%) | - | - |
| Dec 2009 | -$7.88 M(-25.8%) | - | - |
| Dec 2008 | -$10.62 M(+22.7%) | - | - |
| Dec 2007 | -$8.65 M(+6.2%) | - | - |
| Dec 2006 | -$8.15 M(+65.3%) | - | - |
| Dec 2005 | -$4.93 M(+8.7%) | - | - |
| Dec 2004 | -$4.54 M(+23.0%) | - | - |
| Dec 2003 | -$3.69 M(+19.6%) | - | - |
| Dec 2002 | -$3.08 M(-7.3%) | - | - |
| Dec 2001 | -$3.33 M(-25.2%) | - | - |
| Dec 2000 | -$4.45 M(+141.5%) | - | - |
| Dec 1999 | -$1.84 M(-38.8%) | - | - |
| Dec 1998 | -$3.01 M(+19.2%) | - | - |
| Dec 1997 | -$2.52 M(+78.8%) | - | - |
| Dec 1996 | -$1.41 M(+19.7%) | - | - |
| Dec 1995 | -$1.18 M | - | - |
FAQ
- What is the all time high annual FCF for Silence Therapeutics?
- What is the all time high quarterly FCF for Silence Therapeutics?
- What is the all time high TTM FCF for Silence Therapeutics?
What is the all time high annual FCF for Silence Therapeutics?
Silence Therapeutics all-time high annual free cash flow is $7.39 M
What is the all time high quarterly FCF for Silence Therapeutics?
Silence Therapeutics all-time high quarterly free cash flow is $35.30 M
What is the all time high TTM FCF for Silence Therapeutics?
Silence Therapeutics all-time high TTM free cash flow is $18.66 M